Hepatitis and liver damage - how to recognize the disease early?

Hepatitis is an inflammatory condition of the liver that can be acute or chronic, depending on the cause and duration of the disease. Hepatitis is classified in several ways, mainly according to the infectious agent. The main types of hepatitis are hepatitis A, hepatitis B, and hepatitis C, but there are also hepatitis D and E, which are less common.

What is hepatitis?

Definition and types

Hepatitis A is usually acquired through the oral-fecal route, often from contaminated water or food. It is an acute but usually temporary condition that often resolves on its own. Hepatitis B and C, on the other hand, are more often associated with long-term infection, which can lead to chronic liver diseases such as cirrhosis or liver cancer. Hepatitis B is spread through body fluids and is particularly contagious, while hepatitis C is most commonly transmitted through infected blood.

In addition to these, hepatitis D is special in that it can only coexist with hepatitis B because it needs the hepatitis B virus to reproduce. Hepatitis E, which is similar to hepatitis A, is more common in Asia, Africa and Latin America and is spread through contaminated water.

Epidemiology

Hepatitis is a global health problem that affects millions of people every year. According to the World Health Organization, about 257 million people live with chronic hepatitis B, and about 71 million people suffer from chronic hepatitis C. Hepatitis A is more common in regions with poor sanitation, such as many countries in Africa and Southeast Asia. Hepatitis B and C are associated with a high risk of chronic liver disease, which can lead to death if not adequately treated. Vaccination and preventive measures are essential to limit the spread of hepatitis.

The prevalence of hepatitis may vary in different regions of the world. For example, hepatitis B is particularly common in Africa and East Asia, where most infections are acquired in childhood. Hepatitis C, on the other hand, is more common in Central Asia, North Africa and Eastern Europe. These differences may be related to various risk factors, such as the quality of the health care system, sanitation and vaccination coverage.

Causes and risk factors

Viral hepatitis

Viral hepatitis is the most common type of hepatitis and is caused by several different viruses. Hepatitis A virus (HAV) is a simple RNA virus that spreads through contaminated food and water. Thanks to vaccination, hepatitis A is preventable. Hepatitis B virus (HBV) is the most common virus that is transmitted through blood, sexual contact and from mother to child during childbirth. Vaccination is an effective preventive measure against HBV. Hepatitis C virus (HCV) is transmitted mainly through infected blood, and a vaccine is not yet available. These viruses target liver cells, causing them to become inflamed and potentially damaged.

In addition to hepatitis A, B, and C, there is hepatitis D, which depends on HBV to reproduce, and hepatitis E, which spreads in a similar way to hepatitis A. Hepatitis D can cause more severe infections and complications when it occurs at the same time as HBV. Hepatitis E is especially dangerous for pregnant women because it can cause severe complications, such as acute liver failure.

Other causes

Symptoms and diagnostics

Early symptoms

Hepatitis symptoms can vary depending on the type of hepatitis and the severity of the disease. Early symptoms often include fatigue, fever, loss of appetite, nausea and vomiting, and upper abdominal pain. Signs such as jaundice (yellowing of the skin and whites of the eyes), dark urine and light-colored stools are also observed. These symptoms can be mild and do not always clearly indicate hepatitis, so early diagnosis is essential.

Jaundice is one of the most obvious symptoms of hepatitis, which occurs when the liver is unable to process bilirubin efficiently, a substance produced when red blood cells break down. This symptom is characteristic of both acute and chronic hepatitis. In severe disease, complications may develop, such as liver failure, manifested by impaired consciousness, bleeding tendencies, and ascites.

Diagnostic methods

Diagnosis of hepatitis includes several laboratory and imaging methods. Blood tests are primary to determine liver function indicators such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Serological tests are essential to identify the specific hepatitis virus and detect the presence of antibodies that indicate the presence of the virus or previous infection. Hepatitis B surface antigen (HBsAg) and hepatitis C antibody (anti-HCV) tests are standard diagnostic tests. Additional tests, such as viral RNA or DNA quantification, help assess viral load and infection activity. Liver ultrasound and biopsy may be needed to assess the extent of liver damage.

In addition to laboratory tests, imaging techniques such as magnetic resonance imaging (MRI) and computed tomography (CT) can be useful in evaluating the structure of the liver and detecting possible complications such as cirrhosis or liver tumors. Elastography, which uses ultrasound technology, can help assess the degree of liver fibrosis, which is important in chronic hepatitis patients.

Treatment options

Lifestyle changes

Family and community support is important for chronic hepatitis patients, as emotional and social support can improve treatment adherence and quality of life. Psychological counseling can be helpful in dealing with the emotional challenges associated with a chronic illness.

Prevention

Vaccination

Vaccination is an effective way to prevent hepatitis A and B. Hepatitis A vaccine is recommended for children, travelers to high-risk countries, and people at increased risk of infection. The hepatitis B vaccine is included in the childhood vaccination schedule in many countries and is also recommended for adults at increased risk of infection, such as healthcare workers and people with chronic liver disease. Vaccination has been shown to be effective and safe, and its introduction has significantly reduced the prevalence of hepatitis B.

Vaccination strategies are also essential in protecting pregnant women and children against hepatitis B, as vertical transmission from mother to child is one of the main routes of infection. Immunization after birth with hepatitis B vaccine and immunoglobulin helps prevent infection in high-risk newborns.

Hygiene measures

Hygiene measures are essential to prevent the spread of hepatitis A, as it is transmitted through contaminated food and water. Regular hand washing, especially after using the toilet and before eating, is a simple but effective way to prevent infection. Proper food preparation and safe use of water sources are important preventive steps, especially for travelers to regions with low sanitation standards. It is important to follow strict sterilization and hygiene guidelines during blood transfusions and medical procedures to prevent the spread of hepatitis B and C.

Safe medical care practices, such as the use of single-use needles and syringes, are essential to prevent the spread of hepatitis in medical settings. Regular training of healthcare workers on infection control will help reduce occupational risk.

Awareness raising and education

Raising public awareness of the causes, symptoms and prevention methods of hepatitis is essential to reduce the spread of the infection. Education campaigns in schools and workplaces can promote a better understanding of the importance of hygiene and the need for vaccination. Health care facilities and non-governmental organizations can provide informational materials and organize seminars to educate the public about effective prevention measures.

Successful education initiatives also include targeted campaigns in high-risk groups, such as intravenous drug users, to promote safe practices and access to treatment. Community involvement and participation in the implementation of prevention strategies can contribute to improving the health of communities and reducing the prevalence of hepatitis.

Conclusions

Prevention and treatment of hepatitis is a multidimensional task that requires the joint involvement of healthcare professionals, policy makers and the public. Only an integrated approach combining prevention, education and affordable treatment can achieve long-term improvements in public health and reduce the burden of hepatitis.